National Strategy for Alzheimer's Disease and Other Dementias Act

How it changed on the way

18% of the text as introduced was changed or removed by the time it became law (969 words introduced, 976 passed). A committee amended it.

moderate changeintent broadened

The bill kept its core purpose of creating a national dementia strategy but expanded the groups consulted to include other dementia advocacy organizations beyond Alzheimer-specific ones. It also updated the preamble wording and added references to other forms of dementia for consistency.

• The preamble was revised to cover all forms of dementia rather than Alzheimer’s alone.

  Before: “Whereas Alzheimer's disease erodes an individual's independence and eventually causes death;”

  After: “Whereas Alzheimer's disease and other forms of dementia erode an individual's independence and eventually cause death;”

• The list of conference participants was expanded to add other dementia advocacy groups.

  Before: “the Alzheimer Society of Canada and other Alzheimer advocacy groups”

  After: “the Alzheimer Society of Canada, other Alzheimer advocacy groups, and other dementia advocacy groups”

• The subclause listing advocacy representatives was broadened beyond Alzheimer groups.

  Before: “(b) representatives from the Alzheimer Society of Canada and other Alzheimer advocacy groups;”

  After: “(b) representatives from Alzheimer advocacy groups and other dementia advocacy groups;”

How precisely it is written

vagueChallenging the law: HardDisputing a charge: Easy

The Act imposes broad duties on the Minister to create and report on a national strategy with open-ended goals and assistance to provinces. Drafting relies on subjective phrasing and wide discretion rather than fixed rules or measurable tests.

Open to argument

• “develop and implement a comprehensive national strategy to address all aspects of Alzheimer's disease and other forms of dementia”

  Uses undefined scope and 'all aspects' without limiting criteria.

• “improve the situation of persons suffering from Alzheimer's disease and other forms of dementia and decrease the burden of those diseases on Canadian society”

  Subjective standards of improvement and burden invite argument over outcomes.

• “assisting the provinces in developing and disseminating emerging clinical diagnostic and treatment guidelines based on new research”

  Vague on what counts as assistance or emerging guidelines.

• “advise the Minister on any matter related to the health care of persons living with Alzheimer’s disease or other forms of dementia”

  Broad grant of advisory power without boundaries.

Clear-cut

• “within 180 days after the day on which this Act comes into force”

  Fixed timeline creates an objective deadline.

• “appoint no more than 15 members to hold office during pleasure for a term not exceeding three years”

  Numeric cap and term limit are clear and measurable.

• “Meetings of the advisory board must be held at least twice annually”

  Specific frequency requirement leaves little room for interpretation.

Discretion. Almost all content of the strategy, the meaning of cooperation with provinces, the choice of objectives, and the content of reports are left to the Minister and delegated officials with no further statutory constraints or regulations required.

Challenging the law itself. The Act creates no enforceable duties on individuals and engages no clear Charter rights, making a vagueness or overbreadth challenge under s. 7 unlikely to succeed.

Disputing a charge under it. No offences or prohibitions are created, so any claim of breach would immediately fail for lack of applicable standards.

Read by a language model from the royal assent text; every quoted phrase appears in the bill. A reading of the drafting, not legal advice.